Work

Overexpressed HER2 in NSCLC is a possible therapeutic target of EGFR inhibitors.

Year: 2011

Type: article

Source: PubMed

Authors: Nobuyuki Ise, Kazuya Omi, Daisuke Nambara, Shigeki Higashiyama, Katsutoshi Goishi

Institution: Fujirebio (Japan)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1935601260

FWCI: 1.251

Cites: 4

Cited by: 17

Related to: 10